Multiple bacterial subpopulations are present within splenic microcolonies. حسب Justin Greene (306625)

الموضوعات:

Droplet-based microfluidics can be used to model clustered bacterial growth. حسب Justin Greene (306625)

الموضوعات:

Acceptance of the HPV vaccine. حسب Mohammad Delwer Hossain Hawlader (11558838)

الموضوعات: "…considered statistically significant…"

Cues to the action question. حسب Mohammad Delwer Hossain Hawlader (11558838)

الموضوعات: "…considered statistically significant…"

Characteristics of the respondents (n = 2,151). حسب Mohammad Delwer Hossain Hawlader (11558838)

الموضوعات: "…considered statistically significant…"

Determinants of HPV vaccine acceptance. حسب Mohammad Delwer Hossain Hawlader (11558838)

الموضوعات: "…considered statistically significant…"

Quantification of single cell areas during MgOx treatment. حسب Justin Greene (306625)

الموضوعات:

MgOx treatment is not sufficient to alter S10 reporter activity. حسب Justin Greene (306625)

الموضوعات:

Lack of Nat4 increases sensitivity to DNA damage. حسب Mamantia Constantinou (19787239)

ROC Results Predicted in the Sample. حسب Fangyi Yang (18867853)

الموضوعات:

ROC Results Predicted for Out of the Sample. حسب Fangyi Yang (18867853)

الموضوعات:

Lack of T3SS expression was associated with lower S10 expression. حسب Justin Greene (306625)

الموضوعات:

T3SS induction slows growth, but cells can support high levels of S10 expression. حسب Justin Greene (306625)

الموضوعات:

Image 3_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.tiff حسب Qianyi Zhou (6196383)

"…Purpose<p>CD19 chimeric antigen receptor T (CAR-T) cell therapy has shown promise in treating relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL), but cytokine release syndrome (CRS) remains a significant side effect.…"

Table 1_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.docx حسب Qianyi Zhou (6196383)

"…Purpose<p>CD19 chimeric antigen receptor T (CAR-T) cell therapy has shown promise in treating relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL), but cytokine release syndrome (CRS) remains a significant side effect.…"

Image 2_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.tiff حسب Qianyi Zhou (6196383)

"…Purpose<p>CD19 chimeric antigen receptor T (CAR-T) cell therapy has shown promise in treating relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL), but cytokine release syndrome (CRS) remains a significant side effect.…"

Table 2_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.doc حسب Qianyi Zhou (6196383)

"…Purpose<p>CD19 chimeric antigen receptor T (CAR-T) cell therapy has shown promise in treating relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL), but cytokine release syndrome (CRS) remains a significant side effect.…"

Image 1_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.tiff حسب Qianyi Zhou (6196383)

"…Purpose<p>CD19 chimeric antigen receptor T (CAR-T) cell therapy has shown promise in treating relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL), but cytokine release syndrome (CRS) remains a significant side effect.…"

Effect of different doses of the defatted extract (DE) of the leaves of <i>S. malaccense</i> and <i>S. samarangense</i> on urea and creatinine levels. Data represented as mean±SEM... حسب Fatma A. Moharram (9276104)

الموضوعات:

The results of linear mixed model. حسب Soheila Qanbari (20455173)

الموضوعات: